Authors: CHEN GQ SHI XG TANG W XIONG SM ZHU J CAI X HAN ZG NI JH SHI GY JIA PM LIU MM HE KL NIU C MA J ZHANG P ZHANG TD PAUL P NAOE T KITAMURA K MILLER W WAXMAN S WANG ZY DETHE H CHEN SJ CHEN Z

Citation: Gq. Chen et al., USE OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) .1. AS2O3 EXERTS DOSE-DEPENDENT DUAL EFFECTS ON APL CELLS, Blood, 89(9), 1997, pp. 3345-3353

Authors: SHEN ZX CHEN GQ NI JH LI XS XIONG SM QIU QY ZHU J TANG W SUN GL YANG KQ CHEN Y ZHOU L FANG ZW WANG YT MA J ZHANG P ZHANG TD CHEN SJ CHEN Z WANG ZY

Citation: Zx. Shen et al., USE OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APE) .2. CLINICAL EFFICACY AND PHARMACOKINETICS IN RELAPSED PATIENTS, Blood, 89(9), 1997, pp. 3354-3360

Authors: CHEN GQ ZHU J SHI XG NI JH ZHONG HJ SI GY JIN XL TANG W LI XS XONG SM SHEN ZX SUN GL MA J ZHANG P ZHANG TD GAZIN C NAOE T CHEN SJ WANG ZY CHEN Z

Citation: Gq. Chen et al., IN-VITRO STUDIES ON CELLULAR AND MOLECULAR MECHANISMS OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA - AS2O3 INDUCES NB4 CELL APOPTOSIS WITH DOWN-REGULATION OF BCL-2 EXPRESSION AND MODULATION OF PML-RAR-ALPHA PML PROTEINS/, Blood, 88(3), 1996, pp. 1052-1061